Jpmorgan Chase & Co »

Virpax Pharmaceuticals shares owned by Jpmorgan Chase & Co

Quarter-by-quarter ownership of Virpax Pharmaceuticals shares owned by Jpmorgan Chase & Co from 13F filings

Historical chart of Jpmorgan Chase & Co investment in Virpax Pharmaceuticals

Tip: Access up to 7 years of quarterly data

All positions including Virpax Pharmaceuticals held by Jpmorgan Chase & Co consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Virpax Pharmaceuticals by Jpmorgan Chase & Co

Quarter filed Position value Share count Share price at filing
2023-12-31 $1.4k 4.4k 0.32
2022-03-31 $6.0k 2.7k 2.23